Evidence map›Paper›PMID 27917361›Full record

ArticleSpringerPlus2016

Alessandra Mangia, Victor De Ledinghen, François Bailly, Javier Brahm, Jazeps Keiss, Jonas Valantinas, Nele Rasmann, Diethelm Messinger, Fernando Tatsch, Georgios Bakalos and 2 more

Open access · diamondAbstract read
In one paragraph

Article in SpringerPlus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Tropical medicine and infectious disease · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 9 countries.

Alessandra MangiaLiver Unit, IRCCS Hospital 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, 71013 Italy.
Victor De LedinghenHepatology Unit, Hôpital Haut-Lévêque, CHU Bordeaux, 33600 Pessac, France.
François BaillyHepatology Unit, Groupe Hospitalier Nord, CHU Lyon, 69004 Lyon, France.
Javier BrahmGastroenterology Department, University of Chile Clinical Hospital, Santiago, 8380456 Chile.
Jazeps KeissLatvian Centre of Infectious Diseases, LLC Riga East University Hospital, Riga, 1006 Latvia.
Jonas ValantinasCentre of Hepatology, Gastroenterology and Dietetics, Vilnius University, 08661 Vilnius, Lithuania.
Nele RasmannCenter for Infectious Diseases, West Tallinn Central Hospital, 10617 Tallinn, Estonia.
Diethelm MessingerBiostatistics, PROMETRIS GmbH, 68219 Mannheim, Germany.
Fernando TatschGlobal Medical Affairs, F. Hoffmann-La Roche Ltd, 4074 Basel, Switzerland ; AbbVie, North Chicago, IL USA.
Georgios BakalosGlobal Product Development Medical Affairs, F. Hoffmann-La Roche Ltd, 4074 Basel, Switzerland.
Graham R FosterInstitute of Cellular and Molecular Sciences, Queen Mary University of London, London, E1 2AT UK.
Gen-C study group
Roche (Switzerland) · CHCasa Sollievo della Sofferenza · ITHôpital Lyon Sud · FRVilnius University · LTEast Tallinn Central Hospital · EEQueen Mary University of London · GBRiga East University Hospital · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeContradictory data exist on the association between host interleukin-28B (

methodsA total of 3003 adult, treatment-naive CHC patients were enrolled into the study. Patients made one study visit to provide a blood sample for genotyping; other data were obtained from medical records.

results2916 patients comprised the analysis population; the majority were enrolled in Europe (n = 2119), were Caucasian (n = 2582) and had hepatitis C virus (HCV) genotype (G)1 infection (n = 1702) (G2 = 323, G3 = 574, G4 = 260). Distribution of

conclusionThis large, international study found that

Indexed as

Advanced fibrosisChronic hepatitis CGen-C studyHepatitis CIL28B

Identifiers

PMID27917361
PMCPMC5116020
OpenAlexW2556202347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.